Oakbrook Investments’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-22,700
| Closed | -$2.25M | – | 648 |
|
|
2019
Q3 | $2.25M | Sell |
22,700
-4,300
| -16% | -$409K | 0.15% | 95 |
|
|
2019
Q2 | $2.5M | Sell |
27,000
-180
| -0.7% | -$17.1K | 0.15% | 95 |
|
|
2019
Q1 | $2.56M | Sell |
27,180
-24,430
| -47% | -$2.14M | 0.16% | 105 |
|
|
2018
Q4 | $3.31M | Buy |
51,610
+23,860
| +86% | +$1.76M | 0.22% | 72 |
|
|
2018
Q3 | $2.48M | Sell |
27,750
-14,575
| -34% | -$1.29M | 0.14% | 124 |
|
|
2018
Q2 | $3.36M | Sell |
42,325
-4,108
| -9% | -$341K | 0.21% | 79 |
|
|
2018
Q1 | $4.14M | Buy |
46,433
+4,655
| +11% | +$447K | 0.26% | 63 |
|
|
2017
Q4 | $4.36M | Buy |
41,778
+7,425
| +22% | +$838K | 0.28% | 63 |
|
|
2017
Q3 | $5.01M | Sell |
34,353
-5,525
| -14% | -$753K | 0.32% | 56 |
|
|
2017
Q2 | $5.18M | Sell |
39,878
-4,225
| -10% | -$518K | 0.34% | 59 |
|
|
2017
Q1 | $5.49M | Buy |
44,103
+600
| +1% | +$71.8K | 0.36% | 61 |
|
|
2016
Q4 | $5.04M | Sell |
43,503
-10,200
| -19% | -$1.14M | 0.33% | 63 |
|
|
2016
Q3 | $5.61M | Sell |
53,703
-7,900
| -13% | -$855K | 0.34% | 61 |
|
|
2016
Q2 | $6.08M | Buy |
61,603
+17,900
| +41% | +$1.85M | 0.34% | 67 |
|
|
2016
Q1 | $4.37M | Buy |
43,703
+33,625
| +334% | +$3.46M | 0.28% | 77 |
|
|
2015
Q4 | $1.21M | Sell |
10,078
-38,075
| -79% | -$4.41M | 0.08% | 214 |
|
|
2015
Q3 | $5.21M | Buy |
48,153
+38,250
| +386% | +$4.75M | 0.34% | 65 |
|
|
2015
Q2 | $1.15M | Sell |
9,903
-2,850
| -22% | -$326K | 0.07% | 247 |
|
|
2015
Q1 | $1.47M | Buy |
12,753
+925
| +8% | +$111K | 0.08% | 233 |
|
|
2014
Q4 | $1.32M | Buy |
11,828
+4,200
| +55% | +$443K | 0.07% | 248 |
|
|
2014
Q3 | $723K | Sell |
7,628
-115,050
| -94% | -$10.4M | 0.04% | 307 |
|
|
2014
Q2 | $10.5M | Sell |
122,678
-6,000
| -5% | -$456K | 0.32% | 83 |
|
|
2014
Q1 | $8.98M | Sell |
128,678
-118,800
| -48% | -$9.41M | 0.28% | 81 |
|
|
2013
Q4 | $20.9M | Sell |
247,478
-27,222
| -10% | -$2.15M | 0.58% | 44 |
|
|
2013
Q3 | $21.2M | Sell |
274,700
-14,900
| -5% | -$1.04M | 0.62% | 44 |
|
|
2013
Q2 | $16.9M | Buy |
+289,600
| New | +$17.4M | 0.49% | 49 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Oakbrook Investments's CELG Position: Q4 2019 in Review
Oakbrook Investments sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 22,700 shares — an estimated $2.25M sold.
Oakbrook Investments first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $21.2M in Q3 2013. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Oakbrook Investments reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Oakbrook Investments sold 22,700 Celgene Corp shares in Q4 2019, an estimated $2.25M.
- Oakbrook Investments first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Oakbrook Investments's Celgene Corp position peaked at $21.2M in Q3 2013.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Oakbrook Investments's 13F filing for Q4 2019, filed 6 Feb 2020.